Digital Health Today Podcasts

Today, we are more fascinated than ever by how Artificial Intelligence can affect the future of any industry, including healthcare. But AI alone can’t solve healthcare. To make an impact, solutions built with AI have to fit into the right ecosystem to enable better consumer journeys and health outcomes. In this episode, I speak with Prashant Warier, the co-founder and CEO of Qure. Over the past 6 years, he’s learned how to convert the promise of how Artificial Intelligence can be used in Healthcare into three clear use-cases that solve the needs of millions of people across 80 countries. During this podcast, we discuss: • The value of mentors and advisors to help identify disruptive opportunities that drive exponential change in healthcare • How a background in Data Science changed the way to develop effective AI products • The three clear use-cases for AI and Radiology that led to reaching millions of people across 80 countries by focusing on autonomous X-Ray interpretation • How a team of 250 people can scale by building effective partnerships with organisations like Astra Zeneca and the NHS About Prashant Warier Prashant Warier is Founder and CEO of Qure.ai, a leading Artificial Intelligence company in Radiology. He is an expert in the field of artificial intelligence and machine learning and has architected and commercialized several AI solutions during his career. His work has been published in journals such as The Lancet and Nature. He is passionate about using AI and machine learning to make healthcare affordable and accessible. Prashant is an evangelist for the adoption of AI in radiology and has given multiple TedX talks, including one at the largest TedX event in the world in Mumbai. In the past, Prashant was Chief Data Scientist at Fractal.ai and also founded AI - powered advertising technology startup Imagna which was acquired by Fractal.ai in 2015. Guest's Links and Resources Connect with Prashant Warier: LinkedIn Qure.ai Qure Impact Page NHS AI Toolkit Global Health AI Tool Kit (for SEA and India) Episode PDF Host's Links and Resources: Connect with Tony Estrella: Twitter | LinkedIn | Personal Website Connect with Taliossa Read Tony’s Book: Comatose FutureProofing Healthcare | FutureProofing Healthcare APAC index Full White Paper, Summary and Video: A Vision for Asia Pacific in 2050 Follow Digital Health Today: Browse Episodes | Twitter | LinkedIn | Facebook | Instagram Follow Health Podcast Network: Browse Shows | LinkedIn | Twitter | Facebook | Instagram Digital Health Today is made possible by the support of our sponsors. Special thanks to: Amalgam Rx | Bayer G4A | Lindus Health | LSI

In this episode, we hear from Joe Perekupka, CEO of Freespira. In their own words Freespira is 'the only medication-free, FDA-cleared digital therapeutic treatment proven to significantly reduce or eliminate symptoms of panic disorder, panic attacks and post-traumatic stress disorder in just 28 days.' In this episode, we cover: The founding story of Freespira The user experience from prescription to daily use The role of health coaches within Freespira Identifying potential candidates for Freespira The current landscape for panic disorder treatment and research into MDMA-assisted therapies Evidence generation to FDA approval journey Evolving pricing models The scope of PTSD across the US Guest Links and Resources: Connect with Joseph Perekupka on LinkedIn Visit freespira.com Host Links: Connect with Eugene Borukhovich: Twitter | LinkedIn Connect with Chandana Fitzgerald, MD: Twitter | LinkedIn Connect with YourCoach.health: Website | Twitter Check out Shot of Digital Health with Eugene and Jim Joyce: Website | Podcast App HealthXL: Website | Twitter | Join an Event Digital Therapeutics Podcast would not be possible without the support of leading DTx organizations. Thank you to: > Presenting Partner: Amalgam Rx > Sponsors: LSI | Bayer G4A | Lindus Health Follow Digital Health Today: Browse Episodes | Twitter | LinkedIn | Facebook | Instagram Follow Health Podcast Network: Browse Shows | LinkedIn | Twitter | Facebook | Instagram

In this episode, Eugene sits down with Megan Coder, Chief Policy Officer of the Digital Therapeutics Alliance (DTA). Tune in to hear the exciting and positive advancements taking place in the digital therapeutics industry following the DTA Inaugural Summit. Topics include: The success of DTA's first summit in Washington DC Introducing a new definition of DTx The new DTx Evalution Toolkit Developing the new European DTx Policy Report in partnership with Healthware Guest Links and Resources: Connect with Megan Coder on LinkedIn Visit dtxalliance.org Episode PDF Host Links: Connect with Eugene Borukhovich: Twitter | LinkedIn Connect with Chandana Fitzgerald, MD: Twitter | LinkedIn Connect with YourCoach.health: Website | Twitter Check out Shot of Digital Health with Eugene and Jim Joyce: Website | Podcast App HealthXL: Website | Twitter | Join an Event Digital Therapeutics Podcast would not be possible without the support of leading DTx organizations. Thank you to: > Presenting Partner: Amalgam Rx > Contributing Partners and Sponsors: LSI | Bayer G4A | Lindus Health Follow Digital Health Today: Browse Episodes | Twitter | LinkedIn | Facebook | Instagram Follow Health Podcast Network: Browse Shows | LinkedIn | Twitter | Facebook | Instagram

In this episode, we hear from Jenna Carl PhD, Chief Medical Officer at Big Health. Big Health believes in mental health care for all and that their digital therapeutics are safe and effective non-drug options for mental health. In this episode, we cover: Consumer Experience with Sleepio vs Daylight: Gain insights into the end consumer experience and how these solutions are designed to improve sleep and mental well-being. Go-to-Market Strategy: Explore Big Health's go-to-market strategy, and activating employers to reach upstream employees and achieve high engagement rates. Deep Dive into the Relationship with CVS: Gain a deeper understanding of Big Health's relationship with CVS, specifically regarding medication targeting. Abandoning Direct-to-Consumer (DTC): Uncover the reasons behind Big Health's decision to shift away from a direct-to-consumer approach and explore the implications of this strategic shift. Clinical Evidence and Decision-making Processes: Learn about Big Health's extensive clinical study basis and the rationale behind this approach. Future Product Pipeline: Gain insights into Big Health's future plans for additional products and the exciting developments in their pipeline. Big Health and Pear's Differing Go-To-Market Strategies: Explore the differing go-to-market routes between Big Health and Pear Therapeutics Stand-alone DTx vs. Disease Management 2.0: Understand the merits and challenges of stand-alone digital therapeutics versus disease management 2.0 Guest Links and Resources: Connect with Jenna Carl on LinkedIn Visit BigHealth.com Episode PDF Host Links: Connect with Eugene Borukhovich: Twitter | LinkedIn Connect with Chandana Fitzgerald, MD: Twitter | LinkedIn Connect with YourCoach.health: Website | Twitter Check out Shot of Digital Health with Eugene and Jim Joyce: Website | Podcast App HealthXL: Website | Twitter | Join an Event Digital Therapeutics Podcast would not be possible without the support of leading DTx organizations. Thank you to: > Presenting Partner: Amalgam Rx > Contributing Partners and Sponsors: Akili | Bayer G4A | Lindus Health Follow Digital Health Today: Browse Episodes | Twitter | LinkedIn | Facebook | Instagram Follow Health Podcast Network: Browse Shows | LinkedIn | Twitter | Facebook | Instagram

In this episode, Eugene Borukhovich sits down with Aaron Gani, Founder and CEO of BehaVR. BehaVR translates proven science into immersive and engaging XR therapeutics for mental and behavioral health. In this episode, we cover: Origin Story: Aaron Gani shares the origin story of BehaVR, starting from its inception in 2016 and the inspiration behind creating immersive XR therapeutics for mental and behavioral health. Funding Journey and Milestones: Walk through BehaVR's funding journey, uncovering the key milestones achieved with each funding round and how it has shaped the company's growth and impact in the digital therapeutics landscape. Patient Journey Using VR: Gain insights into the end customer experience offered by BehaVR, highlighting the effectiveness of immersive therapeutics in supporting mental well-being. Scientific Hypothesis and Evidence Generation: Explore the hypothesis that BehaVR is built upon and learn how their evidence generation journey is proving the effectiveness of their immersive XR therapeutics, showcasing the power of mind-body connections. Merging with OxfordVR and FDA Approval: Discover the decision-making process behind BehaVR's merger with OxfordVR and their journey towards FDA approval. Business Hypothesis and Scaling Plan: Delve into BehaVR's current business hypothesis and explore their scaling plan. Partnership with Sumitomo Dainippon: Aaron expands on BehaVR's partnership with Sumitomo Dainippon and discusses the commercial arrangement that led to this collaboration. Access to Care: Explore the accessibility of virtual reality therapy and its role in improving access to care for patients. Pear Therapeutics and the Future of PDTs: Aaron shares his thoughts on Pear Therapeutics and discusses the future of Prescription Digital Therapeutics (PDTs), providing insights into the evolving landscape of digital therapeutics and its potential to revolutionize mental health care. Guest Links and Resources: Connect with Aaron Gani on LinkedIn Visit BehaVR Episode PDF Host Links: Connect with Eugene Borukhovich: Twitter | LinkedIn Connect with Chandana Fitzgerald, MD: Twitter | LinkedIn Connect with YourCoach.health: Website | Twitter Check out Shot of Digital Health with Eugene and Jim Joyce: Website | Podcast App HealthXL: Website | Twitter | Join an Event Digital Therapeutics Podcast would not be possible without the support of leading DTx organizations. Thank you to: > Presenting Partner: Amalgam Rx > Contributing Partners and Sponsors: Akili | Bayer G4A | Lindus Health Follow Digital Health Today: Browse Episodes | Twitter | LinkedIn | Facebook | Instagram Follow Health Podcast Network: Browse Shows | LinkedIn | Twitter | Facebook | Instagram

In this episode of DTx Podcast, Eugene Borukhovich sits down with Acacia Parks, Founder of Liquid Amber Consulting. Liquid Amber helps digital health and DTx companies support the claims they want to make using scientific evidence, in the ways that will be compelling to the audiences they care about. Topics include: A Day in the Life of a Chief Science Officer: Gain insights into the role of a Chief Science Officer before Acacia Parks ventured into her own entrepreneurial journey, and get a glimpse into the challenges and responsibilities involved in the position. Liquid Amber: Uncover the story behind the name "Liquid Amber" and explore the mission and vision of the company. Evidence Generation Process: Dive deep into the process of setting up the right processes and PDT vs non PDT. Active Ingredients in DTx: Discover how active ingredients play a crucial role in both molecular-based and software-based interventions. Pro Tips for Regulatory Approvals: Acacia Parks shares her expert advice on getting regulatory approvals for DTx. Learn what companies should do before, during, and right after the regulatory process to streamline the approval journey. Being a Patient on Freespira: Get a firsthand perspective as Acacia Parks walks us through her personal experience using Freespira. Guest Links and Resources: Connect with Acacia Parks on LinkedIn Visit liquidamber.consulting Episode PDF Host Links: Connect with Eugene Borukhovich: Twitter | LinkedIn Connect with Chandana Fitzgerald, MD: Twitter | LinkedIn Connect with YourCoach.health: Website | Twitter Check out Shot of Digital Health with Eugene and Jim Joyce: Website | Podcast App HealthXL: Website | Twitter | Join an Event Digital Therapeutics Podcast would not be possible without the support of leading DTx organizations. Thank you to: > Presenting Partner: Amalgam Rx > Contributing Partners and Sponsors: Akili | Bayer G4A | Lindus Health Follow Digital Health Today: Browse Episodes | Twitter | LinkedIn | Facebook | Instagram Follow Health Podcast Network: Browse Shows | LinkedIn | Twitter | Facebook | Instagram

Engaging with active and well-informed individuals is the essential element of any successful health ecosystem. Without them, healthcare and digital health companies are building solutions that can’t improve health outcomes. Patient advocacy groups are one way that individuals can become empowered. But across the world, the impact of such groups is dependent on external factors to help them achieve scale. In this episode, I speak with Ruth Kuguru, the Regional Head for Communications and Patient Engagement for Novartis who has developed a platform to change this dynamic for patient advocacy groups. During this podcast, we discuss: How Novartis created a platform to bring together different stakeholders and putting patients at the forefront of improving Habitats – another word for Ecosystems Describing the components of the Alliance & Partnerships for Patient Innovation & Solutions (APPIS) including a case study in the Philippines Why patient advocacy groups are the “real deal” for creating engaged individuals Scaling the impact of patient advocacy into a corporate capability that goes beyond the traditional model for pharma manufacturers About Ruth Kuguru Ruth Kuguru is the Executive Director, Communications & Patient Engagement for Novartis Asia Pacific, Middle East, and Africa. In her role, she leads her team to foster open, inclusive, and strong partnerships with patient communities, media, and healthcare leaders in Asia Pacific, Middle East and African countries. She is passionate about the impact strong collaboration can have in accelerating access and developing innovative solutions for patients. Guest's Links and Resources Connect with Ruth Kuguru: LinkedIn Novartis: Website APPIS Summit APPIS Innovator Programme Host's Links and Resources: Connect with Tony Estrella: Twitter | LinkedIn | Personal Website Connect with Taliossa Read Tony’s Book: Comatose FutureProofing Healthcare | FutureProofing Healthcare APAC index Full White Paper, Summary and Video: A Vision for Asia Pacific in 2050 Follow Digital Health Today: Browse Episodes | Twitter | LinkedIn | Facebook | Instagram Follow Health Podcast Network: Browse Shows | LinkedIn | Twitter | Facebook | Instagram Digital Health Today is made possible by the support of our sponsors. Special thanks to: Amalgam Rx | Akili | Bayer G4A | Lindus Health

Join host Tony Estrella each month as he explores with his guests what it takes to build successful ecosystems across Asia-Pacific. You’ll hear thought-provoking interviews with industry leaders, entrepreneurs, and investors who bring real-life examples of building effective partnerships that solve some of the most important healthcare challenges across this vibrant region. Whether you’re already in healthcare, a tech enthusiast, or simply curious about what is happening in Asia-Pacific, tune in to the APAC Edition of Digital Health Today. Host's Links and Resources: Connect with Tony Estrella: Twitter | LinkedIn | Personal Website Connect with Taliossa Read Tony’s Book: Comatose FutureProofing Healthcare | FutureProofing Healthcare APAC index Full White Paper, Summary and Video: A Vision for Asia Pacific in 2050 Follow Digital Health Today: Browse Episodes | Twitter | LinkedIn | Facebook | Instagram Follow Health Podcast Network: Browse Shows | LinkedIn | Twitter | Facebook | Instagram Digital Health Today is made possible by the support of our sponsors. Special thanks to: Amalgam Rx | Akili | Bayer G4A | Lindus Health